Abstract
This chapter outlines practical approach to rapid on-site assessment of fine needle aspiration of thyroid lesions. It discusses the diagnostic considerations in different types of thyroid lesions. It also discusses cytomorphologic features and diagnostic pitfalls of commonly encountered thyroid lesions.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Fine needle aspiration
- Thyroid
- Papillary thyroid carcinoma
- Hashimoto thyroiditis
- Medullary carcinoma
- Anaplastic carcinoma
- Lymphoma
- Metastasis
- Parathyroid
Introduction
Fine needle aspiration (FNA) is the procedure of choice for the evaluation of thyroid nodules. More recently, the implementation of ultrasonographic-guided FNAs of the thyroid has increased the overall diagnostic yield and accuracy of the procedure [1,2,3,4]. However, despite the improvement in diagnostic yield, a significant subset of thyroid FNAs continues to be inadequate for interpretation, and this leads to some uncertainty in the follow-up management for such patients.
The diagnostic yield for thyroid FNA may be affected by several factors such as the nature of the lesion (e.g., size, cystic vs. solid), needle size, skill and level of experience of the operator, as well as the level of experience of the cytopathologist [1]. Many of these factors fluctuate between different institutions; hence one would expect significant variation in FNA adequacy rates. The presence or absence of rapid on-site evaluation (ROSE) by a cytopathologist or a cytotechnologist to assess for specimen adequacy during the FNA procedure is a potential factor, which can greatly affect the yield and can be standardized between institutions. Numerous studies have been published regarding the influence of ROSE on thyroid FNA specimen adequacy, with most of the studies acknowledging that FNA is more likely to be adequate for interpretation with ROSE [2, 5, 6]. More so, ROSE has been shown to decrease the number of needle passes, increase diagnostic accuracy, and reduce the risk for a repeat procedure [7, 8]. Immediate evaluation of the material also allows the opportunity to obtain additional material for cell blocks and/or ancillary studies [9]. This is especially important in suspected cases of medullary thyroid carcinoma, which require immunostaining for calcitonin, and in suspected cases of lymphoma, which require additional material for flow cytometry.
Specimen Adequacy Assessment
Recommendations for optimal specimen preparation include the use of air-dried and alcohol-fixed slides, prepared for Romanowsky and Papanicolaou staining, respectively, with supplemental combinations of liquid-based or cytospin preparations, cell blocks, and RPMI for flow cytometric evaluation where appropriate and possibly sterile material for microbiology. For cyst-fluid-only specimens, only one or two smears are recommended with the remainder being processed as either cytospin or liquid-based preparations.
Examination usually starts with the review of the slides under scanning magnification. This quickly gives significant information as most benign follicular nodules are sparsely cellular, consisting predominantly of colloid. Colloid can be thin and watery, thick and opaque with sharp outlines, or extremely thick and sticky. Smears that have a high ratio of colloid to follicular cells generally indicate a benign thyroid nodule [10]. Some features are generally nonspecific. For instance, macrophages can be seen in cyst contents, benign hyperplastic nodule with cystic degeneration, as well as cystic papillary thyroid carcinoma. In a similar fashion, multinucleated giant cells can be seen in granulomatous diseases, benign hyperplastic nodule with cystic degeneration, papillary carcinoma, and anaplastic carcinoma.
A thyroid FNA specimen is deemed to be satisfactory for evaluation if it has at least six groups of benign, well-visualized follicular cells, with each group consisting at least 10 follicular cells [11, 12]. Tissue fragments with multiple follicles can be split up and counted as separate and distinct groups [13]. Exceptions to this adequacy requirement include: abundance of colloid even in the absence of six follicular groups, abundance of lymphocytes necessitating the diagnosis of lymphocytic thyroiditis, and presence of atypia [14].
Cystic Lesions of the Thyroid
Diagnostic Consideration
Thyroid FNA specimens with abundant histiocytes having few to no follicular cells are interpreted as “fluid cyst only,” under the category of “nondiagnostic” [15, 16] (Fig. 3.1). Numerous macrophages can be seen in a variety of hyperplastic and neoplastic benign and malignant thyroid nodules undergoing cystic degeneration. Benign cysts arising from nodular goiters collapse after drainage. A small number may reaccumulate or bleed immediately following an FNA, necessitating reaspiration. Recurrence with hemorrhagic or chocolate-colored contents is a warning for the possibility of malignancy [17].
Cystic Degeneration in a Hyperplastic Nodule
Cytomorphologic Features
-
Low cellularity.
-
Abundant macrophages.
-
Reactive follicular cell changes.
Tips and Pitfalls
-
Cyst lining cells typically show reactive changes. They have a pulled-out appearance that mimics reparative epithelium (Fig. 3.2).
-
Cases may be diagnosed as FLUS/AUS because of the reparative changes.
-
Dystrophic calcifications can mimic psammoma bodies.
Cystic Papillary Carcinoma
Cytomorphologic Features
-
Tumor can be partially or totally cystic, unilocular or multilocular, or thin or thick walled and may contain residual tumor in the wall [18].
-
Tissue fragments exhibit scalloped borders, and they are arranged in a cartwheel pattern with nuclei at the outside perimeter [17] (Fig. 3.3).
-
Cytologic features commonly seen include three-dimensional fragments, anisonucleosis, nuclear crowding, nuclear enlargement, intranuclear inclusions, and cytoplasmic vacuoles [19, 20] (Fig. 3.4).
Tips and Pitfalls
-
Fine, powdery chromatin of PTC may not be present because the chromatin tends to stain intensely due to degeneration.
-
The combination of macrophages, hemosiderin, and cellular debris in the background may obscure distinction from cystic goiter.
-
Atypical histiocytoid cells of cystic PTC may be difficult to distinguish from clusters of histiocytes with foamy cytoplasm and enlarged nuclei that are seen in cystic degeneration in goiters [21].
Lymphoepithelial Cysts
-
Lymphoepithelial cysts in the thyroid bear close resemblance to their counterparts in the salivary gland.
-
The cysts are lined predominantly by squamous epithelium and focally by columnar epithelium.
-
The epithelium is bordered by a fibrous capsule and surrounded by lymphoid tissue, often with follicles and germinal centers [22].
Lymphocytes-Rich Lesions of the Thyroid
Diagnostic Consideration
Thyroid glands with Hashimoto thyroiditis usually show diffuse enlargement and the gland feels firm and rubbery. FNA is performed only if there is a suspicious nodule that raises the possibility of a coexisting malignancy.
Primary lymphoid neoplasms of the thyroid are uncommon. They are basically of two types: diffuse large B-cell lymphoma (DLBCL) and extranodal marginal zone B-cell lymphoma (ENMZBL) also referred to as MALT lymphomas. MALT lymphomas are low grade and often arise in a background of Hashimoto’s thyroiditis.
Hashimoto Thyroiditis
Cytomorphologic Features
-
Very cellular, with numerous lymphoid cells.
-
The most characteristic feature is the presence of intense infiltration of the gland by polymorphous population of lymphocytes and plasma cells (Figs. 3.5 and 3.6).
-
There may be occasional clusters of Hürthle cells.
-
Normal follicular cells are infrequent or absent altogether.
Tips and Pitfalls
-
The proportion of Hürthle cells varies widely from case to case. When it is present in abundance , the cells may proliferate to form nonneoplastic Hürthle cell nodules, with little to no lymphoid infiltrate , thereby making it difficult to distinguish from Hürthle cell neoplasm on cytologic preparations. The cells of Hürthle cell neoplasm, however, usually have more prominent nucleoli and they usually do not have a prominent lymphoid infiltrate [10].
-
In florid Hashimoto thyroiditis with atrophy of the follicular cells, lymphocytes predominate, often forming follicles and germinal centers and may be difficult to distinguish from intrathyroidal lymph node sampling . Often this can also lead to a misdiagnosis of malignant lymphoma [23]. When in doubt, additional material should be collected at the time of ROSE for ancillary studies like flow cytometry.
-
Occasionally, multinucleated giant cells are seen and this may lead to confusion with subacute thyroiditis.
-
Syncytial tissue fragments of follicular epithelium with papillary-like architecture can often be seen in Hashimoto thyroiditis and can lead to a misdiagnosis of papillary carcinoma especially when the Hürthle cells display reactive nuclear changes like chromatin clearing, nuclear enlargement, and occasional grooves [18].
Lymphoid Neoplasms of the Thyroid
Cytomorphologic Features
Diffuse Large B-Cell Lymphoma
-
Variable cellularity, usually very cellular.
-
Dense and monomorphous population of poorly differentiated lymphoid cells, which are usually larger than the normal lymphocytes (Fig. 3.7).
-
Cells are large, with high nuclear/cytoplasmic (N:C) ratio and finely granular chromatin.
-
Nucleoli may be small or large.
-
Mitotic activity is frequent and Karyorrhexis is a common feature.
-
Cytomorphologic features of Hashimoto thyroiditis may be present on the smear.
MALT Lymphoma
-
Polymorphous population of lymphocytes and plasma cells (Fig. 3.8).
Tips and Pitfalls
-
DLBCL cells are often seen in large aggregates and this may lead to misdiagnosis as an epithelial neoplasm, most notably anaplastic carcinoma and metastatic carcinoma.
-
MALT lymphoma can be very difficult to differentiate from the florid lymphoid phase of Hashimoto thyroiditis because of the heterogeneous population of lymphocytes and both entities may coexist [23].
-
Additional material should be obtained at the time of ROSE for immunohistochemical stains.
-
Flow cytometry is an important ancillary study and additional material should be obtained at the time of ROSE in RPMI solution for flow cytometry.
Papillary Thyroid Carcinoma
Diagnostic Consideration
Papillary thyroid carcinoma (PTC) is defined based on nuclear features. The classic PTC has true papillary architecture, but there are a large number of PTC variants with some having virtually no papillary architecture. It is important to be aware of these variants so that they are not confused with other neoplasms. Some of the variants have a tendency toward more aggressive clinical behavior than the classic PTC; hence it is important to be able to recognize them as such.
Cytomorphologic Features
-
Smears may show papillary structures, sheets, loosely cohesive groups, or syncytial fragments (Fig. 3.9).
-
Cellularity is variable. A large majority of cases is overwhelmingly cellular, whereas cellularity may be scant in tumors with desmoplastic reaction, or those with cystic change.
-
Nuclear crowding/overlapping.
-
The hallmark feature of PTC is the presence of nuclear features such as nuclear enlargement, membrane irregularity, nuclear grooves, nuclear elongation, powdery chromatin, pseudoinclusions, and nucleoli (which may be small or large and may be single or multiple) (Fig. 3.10).
-
Cytoplasm is variable – from scant in conventional PTC to abundant, squamoid, vacuolated, or Hürthle-like in other cytomorphologic variants.
-
Concentric laminated calcifications also known as psammoma bodies.
-
Multinucleated foreign body-type giant cells almost always present with variable number and size of nuclei.
Tips and Pitfalls
-
Psammoma bodies must be distinguished from nonspecific, dystrophic calcifications, which are not laminated.
-
The presence of conventional PTC nuclear features helps to distinguish oncocytic variant of PTC from Hürthle cell neoplasm. However, the presence of pale chromatin and nuclear grooves is well recognized in Hürthle cells in the absence of PTC [24].
-
Tall cell variant of PTC is characterized by neoplastic cells whose height is at least twice their width and the tall cells must comprise at least 30% of the tumor cell population. The tall cells are not as prominent in cytologic preparations as they are on histology. They are frequently seen as large polygonal cells with abundant granular eosinophilic cytoplasm, thereby resembling Hürthle cells [25, 26] (Fig. 3.11).
-
The neoplastic cells in columnar variant of PTC are pseudostratified and columnar, but the nuclei do not necessarily demonstrate the typical nuclear features of PTC, and hence the tumor may be confused with metastatic adenocarcinoma to the thyroid.
-
Although not entirely specific for the diffuse sclerosing variant of PTC, features such as numerous psammoma bodies, metaplastic squamous epithelium, and marked lymphocytic infiltration are typically seen. The presence of marked lymphocytic infiltrate can obscure the neoplastic follicular cells, mimicking lymphocytic thyroiditis.
-
Papillary structures are often not present in solid variant of PTC, and the presence of cohesive syncytial-type tissue fragments, microfollicular/trabecular pattern, or dyshesive single-cell pattern may lead to misdiagnosis of other types of thyroid carcinoma such as poorly differentiated carcinoma, follicular variant of PTC, or medullary carcinoma [27, 28] (Figs. 3.12 and 3.13).
Medullary Carcinoma
Diagnostic Consideration
Medullary carcinoma has a wide spectrum of cytomorphologic patterns and hence can mimic a variety of neoplasms. At the time of ROSE, additional pass for cell block material should be obtained if there is a suspicion of medullary carcinoma. This is important because FNA cannot always distinguish medullary carcinoma based on cytology alone, and often, immunohistochemical stain for calcitonin is a useful ancillary study.
Cytomorphologic Features
-
Usually highly cellular aspirate, although scant cellularity may be seen with carcinomas containing extensive amyloid deposits and calcification.
-
There is a wide spectrum of cytologic features in medullary carcinoma. It is monomorphic if only one cytomorphologic pattern is evident and polymorphic if a combination of different cytomorphologic patterns is seen.
-
Tumor cells are predominantly single cells with abundant granular cytoplasm but may also be seen as sheets, loose clusters, syncytia, rosettes, cords, and papillae [29,30,31] (Figs. 3.14 and 3.15).
-
Cells are usually uniform in size and shape but occasionally can present as large, pleomorphic cells. Nuclei are eccentrically placed, giving the cells a plasmacytoid appearance. Binucleation and multinucleation are common. Intranuclear inclusions are frequently seen (Figs. 3.16 and 3.17).
Tips and Pitfalls
-
The presence of papillary architecture can mimic papillary carcinoma especially in the presence of intranuclear inclusions and psammoma bodies.
-
Tumor cell arrangement as rosettes or microfollicles can mimic a follicular neoplasm or Hürthle cell neoplasm.
-
Tumor cell arrangement as cords can mimic poorly differentiated carcinoma, especially the insular type.
-
Dispersed single-cell pattern can mimic a lymphoma. When the single cells have prominent plasmacytoid appearance, they can mimic a plasmacytoma.
-
Tumors with a predominant spindle cell component can mimic sarcoma, melanoma, or spindle cell carcinoma.
-
Amyloid can be confused with thick colloid. If in doubt, additional material should be obtained at the time of ROSE for cell block on which Congo red stain may be performed.
Anaplastic Carcinoma
Diagnostic Consideration
The history is very important in this entity as patients present with rapidly enlarging neck mass which has often metastasized to adjacent structures by the time of diagnosis.
Cytomorphologic Features
-
Usually very cellular specimen.
-
Noncohesive, large cells with marked nuclear pleomorphism (Figs. 3.18 and 3.19).
-
Cells may be epithelioid or spindle-shaped.
-
Multinucleated giant cells are usually present.
-
Extensive necrosis is common, mitoses are numerous, and the Ki67 proliferation index is high [32].
-
A good number is associated with a differentiated thyroid carcinoma so marked atypia and pleomorphism may not be prevalent, depending on sampled areas of the tumor.
Tips and Pitfalls
-
Anaplastic carcinoma with extensive collagen deposition can mimic Riedel’s thyroiditis. The stromal spindle cells from Riedel’s thyroiditis are however bland, in comparison to anaplastic carcinoma cells [18].
-
Anaplastic carcinoma cells can be confused with radioactive iodine-induced changes in benign follicular cells after treatment for Graves’ disease. These changes include cytomegaly, clumped chromatin, and nucleoli.
-
When ossified laryngeal or thyroid cartilage containing hematopoietic tissue is inadvertently sampled, megakaryocytes may mimic anaplastic carcinoma cells. However, megakaryocytes lack the malignant features exhibited by anaplastic carcinoma cells.
-
Anaplastic carcinoma cells can mimic poorly differentiated squamous cell carcinoma from direct extension from an adjacent organ in the head and neck. Also, when anaplastic carcinoma has extensive squamous differentiation, it can be mistaken for squamous cell carcinoma [18].
-
The medium to large cells of large cell lymphoma, exhibiting high N/C ratios and scant cytoplasm, can sometimes be difficult to differentiate from cells of malignant lymphoma.
-
Anaplastic carcinoma can often have a spindle cell pattern, simulating cytologic features of sarcoma.
-
Immunohistochemistry can be helpful in the differential diagnosis of anaplastic carcinoma, so additional material should be obtained at the time of ROSE for this purpose.
Metastatic Neoplasms to the Thyroid
Diagnostic Consideration
The possibility of metastasis should always be considered whenever a patient with a history of malignancy elsewhere in the body presents with a thyroid nodule. The thyroid may also be involved by direct extension of malignancies from the head and neck region.
Cytomorphologic Features
-
The cytomorphologic pattern of a metastatic tumor depends on the manner of thyroid involvement, the histologic type, and stage of the tumor.
-
Cytologic features of metastasis are distinct and different from what is usually seen in primary thyroid tumors . However, there can be an admixture of the tumor with atypical follicular cells [18].
Tips and Pitfalls
-
It can be difficult to differentiate between metastatic clear cell renal cell carcinoma and dominant clear cell component within a primary thyroid follicular neoplasm. It may also be difficult to distinguish metastatic clear cell RCC with granular cytoplasm from Hürthle cell neoplasm [18].
-
In a patient with a history of breast carcinoma, the presence of single-file pattern of cells and intracytoplasmic lumina is consistent with breast origin [33] (Fig. 3.20).
-
Neoplastic cells from metastatic lung adenocarcinoma are usually arranged in three-dimensional clusters and gland-forming clusters. Intranuclear cytoplasmic inclusions may be present and may lead to a misdiagnosis of PTC [34] (Fig. 3.21).
-
Benign metaplastic changes seen in the thyroid can mimic squamous cell carcinoma.
-
Anaplastic thyroid carcinoma with prominent squamous differentiation can mimic metastatic squamous cell carcinoma.
-
In metastatic malignant melanoma, cells may present with clearing of the chromatin, poorly formed nuclear grooves, and intranuclear cytoplasmic inclusions and may lead to a misdiagnosis as PTC [35].
-
Whenever metastasis to the thyroid is suspected, especially when there is a history of malignant neoplasms in a different body site, additional material should be obtained at the time of ROSE for immunohistochemical stains and/or molecular studies.
Parathyroid Tissue Sampling
Diagnostic Consideration
Thyroid tissue has overlapping cytomorphologic features with parathyroid tissue so it may be difficult to distinguish one from the other on FNA [36, 37].
Cytomorphologic Features
-
High cellularity.
-
Cells are arranged as cohesive sheets, ribbon-like cords, and occasional microacini (Fig. 3.22).
-
Isolated cells and naked nuclei can be present.
-
Round nuclei with stippled chromatin pattern (Fig. 3.23).
-
Nucleoli may be absent, small, or prominent.
-
Cytoplasm is scant to moderate.
Tips and Pitfalls
-
Colloid-like material can be produced by hyperplastic parathyroid glands and this can be confused with true colloid [38].
-
Parathyroid adenoma smears can show tissue fragments with papillary-like architecture and may be misdiagnosed as papillary carcinoma (Fig. 3.24). Smears with the presence of papillary-like architecture alone without the usual nuclear features of papillary carcinoma should be read with caution [18].
-
Parathyroid smears may be interpreted as follicular neoplasm when the cells present as tight, small, three-dimensional clusters in the absence of colloid.
-
Oncocytic parathyroid adenoma may have follicular structures and can also have colloid-like material in the background, which may lead to a misdiagnosis of Hürthle cell neoplasm. However, Hürthle cell neoplasms of the thyroid have much larger and more prominent nucleoli, and the cells tend to be more discohesive [39, 40].
-
When there is a suspicion of parathyroid tissue during ROSE for a thyroid FNA, additional material should be collected for parathyroid hormone (PTH) and/or thyroglobulin immunohistochemical stains. It may also be important to send additional sample for parathyroid assay.
Ectopic Thyroid Tissue
Diagnostic Consideration
The finding of thyroid tissue in the FNA of a neck mass that is unconnected to the thyroid gland can pose a diagnostic dilemma. The challenge is always to determine whether the aspirate represents a metastatic thyroid malignancy , ectopic thyroid tissue, or benign thyroid inclusion in a lymph node.
Cytomorphologic Features
-
The cytomorphologic features of ectopic thyroid tissue ranges from normal-appearing follicular cells that are reminiscent of hyperplasia, presence of follicular cells and polymorphous population of lymphocytes in lymphocytic thyroiditis, to rarely, presence of cytologic features of malignancy.
-
The presence of a few cytologic features such as unequivocal nuclear features of papillary carcinoma and psammoma bodies is diagnostic of metastases.
Tips and Pitfalls
-
Although benign thyroid inclusions may be present in lymph nodes, the presence of thyroid tissue in lateral neck nodes almost always represents nodal metastases from a primary thyroid carcinoma [41, 42].
-
The presence of cytologically benign-appearing follicular cells does not necessarily imply a benign process because the pattern of growth of certain thyroid carcinomas may be so well differentiated that they can simulate a nonneoplastic thyroid tissue.
-
The presence of cytologic or architectural atypia in follicular cells, even if accompanied by a lymphoid background, does not always indicate metastatic thyroid carcinoma.
Material for Molecular Tests
Molecular testing improves the diagnostic accuracy of FNA for cases in the indeterminate category [43]. It may also provide significant prognostic and therapeutic information preoperatively [44]. The currently available molecular testing can be classified into those involving somatic mutation markers and those involving gene expression classifiers [45]. Several studies have also identified differential expression of several miRNA expressions in thyroid cancers when compared with benign thyroid tissues [45]. More recently, next-generation sequencing has emerged, thus allowing the simultaneous sequencing of large panels of genes [46].
Appropriate and adequate specimen collection at the time of ROSE is key to the success in performance of these tests. It is important to ensure that the specimen/pass evaluated at the time of ROSE is adequately represented in the material sent off for molecular tests.
References
Witt BL, Schmidt RL. Rapid onsite evaluation improves the adequacy of fine-needle aspiration for thyroid lesions: a systematic review and meta-analysis. Thyroid. 2013;23:428–35.
Redman R, Zalaznick H, Mazzaferri EL, Massoll NA. The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules. Thyroid. 2006;16:55–60.
Yang GC, Liebeskind D, Messina AV. Ultrasound-guided fine-needle aspiration of the thyroid assessed by Ultrafast Papanicolaou stain: data from 1135 biopsies with a two- to six-year follow-up. Thyroid. 2001;11:581–9.
Marqusee E, Benson CB, Frates MC, Doubilet PM, Larsen PR, Cibas ES, Mandel SJ. Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med. 2000;133:696–700.
Ghofrani M, Beckman D, Rimm DL. The value of onsite adequacy assessment of thyroid fine-needle aspirations is a function of operator experience. Cancer. 2006;108:110–3.
Berner A, Sigstad E, Pradhan M, Grøholt KK, Davidson B. Fine-needle aspiration cytology of the thyroid gland: comparative analysis of experience at three hospitals. Diagn Cytopathol. 2006;34:97–100.
Moberly AC, Vural E, Nahas B, Bergeson TR, Kokoska MS. Ultrasound-guided needle aspiration: impact of immediate cytologic review. Laryngoscope. 2010;120:1979–84.
Zhu W, Michael CW. How important is on-site adequacy assessment for thyroid FNA? An evaluation of 883 cases. Diagn Cytopathol. 2007;35:183–6.
Pitman MB, Abele J, Ali SZ, et al. Techniques for thyroid FNA: a synopsis of the National Cancer Institute thyroid fine-needle aspiration state of the science conference. Diagn Cytopathol. 2008;36:407–24.
Cibas ES. Thyroid. In: Cibas ES, Ducatman BS, editors. Cytology: diagnostic principles and clinical correlates. Philadelphia: Saunders Elsevier; 2009. p. 255–84.
Goellner JR, Gharib H, Grant CS, Johnson DA. Fine needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol. 1987;31:587–90.
Grant CS, Hay ID, Gough IR, McCarthy PM, Goellner JR. Long-term follow-up of patients with benign thyroid fine-needle aspiration cytologic diagnoses. Surgery. 1989;106:980–5.
Hamburger JI, Husain M. Semiquantitative criteria for fine-needle biopsy diagnosis: reduced false-negative diagnoses. Diagn Cytopathol. 1988;4:14–7.
Renshaw AA. Accuracy of thyroid fine-needle aspiration using receiver operator characteristic curves. Am J Clin Pathol. 2001;116:477–82.
Jaragh M, Carydis VB, MacMillan C, Freeman J, Colgan TJ. Predictors of malignancy in thyroid fine-needle aspirates “cyst fluid only” cases: can potential clues of malignancy be identified? Cancer. 2009;117:305–10.
Baloch Z, LiVolsi V, Asa S, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute thyroid fine-needle aspiration state of the science conference. Diagn Cytopathol. 2008;36:425–37.
Kini SR. Thyroid cytopathology: an atlas and text. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2008.
Adeniran AJ, Chhieng D. Common diagnostic pitfalls in thyroid cytopathology. New York: Springer; 2016.
Kini SR, Miller JM, Hamburger JI, Smith MJ. Cytopathology of papillary carcinoma of the thyroid by fine needle aspiration. Acta Cytol. 1980;24:511–21.
Kaur A, Jayaram G. Thyroid tumors: cytomorphology of papillary carcinoma. Diagn Cytopathol. 1991;7:462–8.
Renshaw AA. “Histiocytoid” cells in fine-needle aspirations of papillary carcinoma of the thyroid: frequency and significance of an under-recognized cytologic pattern. Cancer. 2002;96:240–3.
Louis DN, Vickery AL Jr, Rosai J, Wang CA. Multiple branchial cleft-like cysts in Hashimoto’s thyroiditis. Am J Surg Pathol. 1989;13:45–9.
DeMay RM. The art and science of cytopathology: superficial aspiration cytology. Chicago: ASCP Press; 2012.
Renshaw AA. Fine-needle aspirations of papillary carcinoma with oncocytic features: an expanded cytologic and histologic profile. Cancer Cytopathol. 2011;119:247–53.
Lee SH, Jung CK, Bae JS, Jung SL, Choi YJ, Kang CS. Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma. Diagn Cytopathol. 2014;42:11–7.
Guan H, Vandenbussche CJ, Erozan YS, et al. Can the tall cell variant of papillary thyroid carcinoma be distinguished from the conventional type in fine needle aspirates? A cytomorphologic study with assessment of diagnostic accuracy. Acta Cytol. 2013;57:534–42.
Nikiforov YE, Erickson LA, Nikiforova MN, Caudill CM, Lloyd RV. Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol. 2001;25:1478–84.
Giorgadze TA, Scognamiglio T, Yang GC. Fine-needle aspiration cytology of the solid variant of papillary thyroid carcinoma: a study of 13 cases with clinical, histologic, and ultrasound correlations. Cancer Cytopathol. 2015;123(2):71–81.
Papaparaskeva K, Nagel H, Droese M. Cytologic diagnosis of medullary carcinoma of the thyroid gland. Diagn Cytopathol. 2000;22:351–8.
Forrest CH, Frost FA, de Boer WB, Spagnolo DV, Whitaker D, Sterrett BF. Medullary carcinoma of the thyroid: accuracy of diagnosis of fine-needle aspiration cytology. Cancer. 1998;84:295–302.
Us-Krasovec M, Auersperg M, Bergant D, Golouh R, Kloboves-Prevodnik V. Medullary carcinoma of the thyroid gland: diagnostic cytopathological characteristics. Pathologica. 1998;90:5–13.
Lloyd RV, Osamura RY, Kloppel G, Rosai J, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine organs. Lyon, France: IARC Press; 2017.
Schmid KW, Hittmair A, Ofner C, Tötsch M, Ladurner D. Metastatic tumors in fine needle aspiration biopsy of the thyroid. Acta Cytol. 1991;35:722–4.
Bellevicine C, Vigliar E, Malapelle U, Carelli E, Fiorelli A, Vicidomini G, Cappabianca S, Santini M, Troncone G. Lung adenocarcinoma and its thyroid metastasis characterized on fine-needle aspirates by cytomorphology, immunocytochemistry, and next-generation sequencing. Diagn Cytopathol. 2015;43:585–9.
Miiji LO, Nguyen GK. Metastatic melanoma of the thyroid mimicking a papillary carcinoma in fine-needle aspiration. Diagn Cytopathol. 2005;32:374–6.
Dimashkieh H, Krishnamurthy S. Ultrasound guided fine needle aspiration biopsy of parathyroid gland and lesions. Cytojournal. 2006;3:6.
Tseleni-Balafouta S, Gakiopoulou H, Kavantzas N, Agrogiannis G, Givalos N, Patsouris E. Parathyroid proliferations: a source of diagnostic pitfalls in FNA of thyroid. Cancer. 2007;111:130–6.
Odronic SI, Reynolds JP, Chute DJ. Cytologic features of parathyroid fine-needle aspiration on ThinPrep preparations. Cancer Cytopathol. 2014;122:678–84.
Sriphrapradang C, Sornmayura P, Chanplakorn N, Trachoo O, Sae-Chew P, Aroonroch R. Fine-needle aspiration cytology of parathyroid carcinoma mimic Hürthle cell thyroid neoplasm. Case Rep Endocrinol. 2014;2014:680876.
Paker I, Yilmazer D, Yandakci K, Arikok AT, Alper M. Intrathyroidal oncocytic parathyroid adenoma: a diagnostic pitfall on fine-needle aspiration. Diagn Cytopathol. 2010;38:833–6.
Kozol RA, Geelhoed GW, Flynn SD, Kinder B. Management of ectopic thyroid nodules. Surgery. 1993;114:1103–6. discussion 1106–7.
Butler JJ, Tulinius H, Ibanez ML, Ballantyne AJ, Clark RL. Significance of thyroid tissue in lymph nodes associated with carcinoma of the head, neck or lung. Cancer. 1967;20:103–12.
Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance. Acta Cytol. 2011;55:570–5.
Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC. Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study. Thyroid. 2011 Jul;21:717–23.
Alexander EK, Schorr M, Klopper J, Kim C, Sipos J, Nabhan F, Parker C, Steward DL, Mandel SJ, Haugen BR. Multicenter clinical experience with the Afirma gene expression classifier. J Clin Endocrinol Metab. 2014;99:119–25.
Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, Gooding WE, LeBeau SO, Ohori NP, Seethala RR, Tublin ME, Yip L, Nikiforova MN. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Thyroid. 2015;25:1217–23.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Adeniran, A.J. (2019). Thyroid. In: Cai, G., Adeniran, A. (eds) Rapid On-site Evaluation (ROSE). Springer, Cham. https://doi.org/10.1007/978-3-030-21799-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-21799-0_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21798-3
Online ISBN: 978-3-030-21799-0
eBook Packages: MedicineMedicine (R0)